These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 31707943
1. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System. Dorsch MP, Lester CA, Ding Y, Joseph M, Brook RD. J Am Heart Assoc; 2019 Nov 19; 8(22):e014709. PubMed ID: 31707943 [Abstract] [Full Text] [Related]
2. Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study. Eastwood SV, Mathur R, Sattar N, Smeeth L, Bhaskaran K, Chaturvedi N. PLoS Med; 2021 Jun 19; 18(6):e1003672. PubMed ID: 34185782 [Abstract] [Full Text] [Related]
3. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study. Gamboa CM, Colantonio LD, Brown TM, Carson AP, Safford MM. J Am Heart Assoc; 2017 May 10; 6(5):. PubMed ID: 28490523 [Abstract] [Full Text] [Related]
4. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. Jacobs JA, Addo DK, Zheutlin AR, Derington CG, Essien UR, Navar AM, Hernandez I, Lloyd-Jones DM, King JB, Rao S, Herrick JS, Bress AP, Pandey A. JAMA Cardiol; 2023 May 01; 8(5):443-452. PubMed ID: 36947031 [Abstract] [Full Text] [Related]
5. Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors. Hsu CY, Chen WJ, Chen HM, Tsai HY, Hsiao FY. J Clin Pharm Ther; 2021 Apr 01; 46(2):415-423. PubMed ID: 33180353 [Abstract] [Full Text] [Related]
8. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Zupec JF, Marrs JC, Saseen JJ. Ann Pharmacother; 2016 Jan 01; 50(1):17-21. PubMed ID: 26416950 [Abstract] [Full Text] [Related]
10. Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017-2020. Chobufo MD, Regner SR, Zeb I, Lacoste JL, Virani SS, Balla S. Eur J Prev Cardiol; 2022 Oct 20; 29(14):1830-1838. PubMed ID: 35653373 [Abstract] [Full Text] [Related]
11. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines. Steen DL, Khan I, Ansell D, Sanchez RJ, Ray KK. BMJ Open; 2017 Feb 17; 7(2):e013255. PubMed ID: 28213597 [Abstract] [Full Text] [Related]
12. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD. J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901 [Abstract] [Full Text] [Related]
13. Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients. Blackman AL, Pandit NS, Pincus KJ. HIV Med; 2020 Mar 03; 21(3):135-141. PubMed ID: 31876122 [Abstract] [Full Text] [Related]
14. Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014. Gu A, Kamat S, Argulian E. Diabetes Res Clin Pract; 2018 May 03; 139():1-10. PubMed ID: 29476887 [Abstract] [Full Text] [Related]
15. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients. Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ. J Am Heart Assoc; 2017 Mar 17; 6(3):. PubMed ID: 28314797 [Abstract] [Full Text] [Related]
16. Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk. Kohli-Lynch CN, Bellows BK, Thanassoulis G, Zhang Y, Pletcher MJ, Vittinghoff E, Pencina MJ, Kazi D, Sniderman AD, Moran AE. JAMA Cardiol; 2019 Oct 01; 4(10):969-977. PubMed ID: 31461121 [Abstract] [Full Text] [Related]
17. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study. Yang Q, Zhong Y, Gillespie C, Merritt R, Bowman B, George MG, Flanders WD. BMJ Open; 2017 Jan 24; 7(1):e011684. PubMed ID: 28119384 [Abstract] [Full Text] [Related]
18. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry. Lowenstern A, Li S, Navar AM, Virani S, Lee LV, Louie MJ, Peterson ED, Wang TY. Am Heart J; 2018 Jun 24; 200():118-124. PubMed ID: 29898839 [Abstract] [Full Text] [Related]
20. Statin Prescribing Patterns: An Analysis of Data From Patients With Diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey Databases, 2005-2010. Pauff BR, Jiroutek MR, Holland MA, Sutton BS. Clin Ther; 2015 Jun 01; 37(6):1329-39. PubMed ID: 25869626 [Abstract] [Full Text] [Related] Page: [Next] [New Search]